Improving Drug Development and Decision-Making with AI
In This Episode
Explore transformative technologies and solutions in the life sciences industry. In this episode, join host Dr. Amar Drawid as he sits down with Dimitrios Skaltsas, CEO and co-founder of Intelligencia AI. Together, they delve into how Intelligencia AI harnesses AI-powered solutions to drive data-driven decision-making in clinical trials. Discover how Intelligencia AI is revolutionizing the biopharmaceutical landscape by harmonizing clinical and biological data, accelerating and de-risking clinical development processes. Gain insights into their innovative approach, which enables faster and more accurate predictions around regulatory approvals, setting new standards in clinical trial efficiency and efficacy. Tune in to explore how AI is reshaping the future of drug discovery and transforming the biopharmaceutical industry.
- Delving into how drug development can be enhanced using AI in decision-making.
- Discovering how Intelligencia AI addresses the formidable challenges in drug development.
- Understanding how Intelligencia AI reduces costs and shortens timelines from lab to patient.
- Exploring how biopharmaceutical companies make pipeline decisions about clinical trials and the potential for AI to enable faster and better decision-making on which programs to advance.
Our Host
Dr. Amar Drawid
Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Our Speaker
Dimitrios Skaltsas
Dimitrios Skaltsas brings extensive experience in healthcare and life sciences. Before launching Intelligencia AI, Dimitrios spent over a decade in leadership roles within the industry. He spearheaded McKinsey's new ventures for big data and AI in pharmaceutical R&D. There, he pioneered machine learning-enabled enterprise products in life sciences. Before his work in health tech, Dimitrios began his career as an attorney. He holds an MBA from INSEAD and a law degree from both the University College of London and the University of Athens, highlighting his expertise in both business and legal aspects of industry.
.avif)
.avif)
.avif)
.avif)
